Novo Nordisk wins trademark fight; Indian court to decide fate of Dr Reddy’s stock
Novo Nordisk and Dr. Reddy’s Laboratories' trademark clash over “Olymviq” shifted to stock fate, with an Indian court weighing sell-off versus relabeling risks, rejecting destruction and considering a limited sell-through. A...To view the full article, register now.
Already a subscriber? Click here to view full article